Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Sponsor: University of Alabama at Birmingham
A PHASE3 clinical study on Recurrent Bacterial Vaginosis, this trial is completed. The trial is conducted by University of Alabama at Birmingham and has accumulated 12 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE3
▶ Show 7 earlier versions
-
May 2020 — Jan 2021 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
May 2019 — May 2020 [monthly]
Active Not Recruiting PHASE3
-
Apr 2019 — May 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Nov 2018 — Apr 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Alabama at Birmingham
- Wayne State University
For direct contact, visit the study record on ClinicalTrials.gov .